These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5288735)

  • 21. [Liquid crystals and liquid crystal dispersions of DNA-daunomycin complexes].
    Evdokimov IuM; Salianov VI; Skuridin SG; Badaev NS
    Mol Biol (Mosk); 1995; 29(1):180-91. PubMed ID: 7723758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol.
    Erb N; Erttmann R; Landbeck G
    Cancer Chemother Pharmacol; 1986; 17(1):53-5. PubMed ID: 3698178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daunomycin intercalation stabilizes distinct backbone conformations of DNA.
    Trieb M; Rauch C; Wellenzohn B; Wibowo F; Loerting T; Mayer E; Liedl KR
    J Biomol Struct Dyn; 2004 Apr; 21(5):713-24. PubMed ID: 14769064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anthracycline antitumor antibiotic nucleic-acid interactions. Structural aspects of the daunomycin poly(dA-dT) complex in solution.
    Patel DJ; Canuel LL
    Eur J Biochem; 1978 Oct; 90(2):247-54. PubMed ID: 710429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model.
    Cassidy J; Duncan R; Morrison GJ; Strohalm J; Plocova D; Kopecek J; Kaye SB
    Biochem Pharmacol; 1989 Mar; 38(6):875-9. PubMed ID: 2930589
    [No Abstract]   [Full Text] [Related]  

  • 26. Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin.
    Frederick CA; Williams LD; Ughetto G; van der Marel GA; van Boom JH; Rich A; Wang AH
    Biochemistry; 1990 Mar; 29(10):2538-49. PubMed ID: 2334681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extraction and quantification of daunomycin and doxorubicin in tissues.
    Strauss JF; Kitchens RL; Patrizi VW; Frenkel EP
    J Chromatogr; 1980 Nov; 221(1):139-44. PubMed ID: 7451615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of daunomycin on platelets in vitro.
    Whaun JM; Clarke HD
    Arch Int Pharmacodyn Ther; 1989; 300():292-304. PubMed ID: 2619425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential binding of daunomycin to 5'ATCG and 5'ATGC sequences revealed by footprinting titration experiments.
    Chaires JB; Herrera JE; Waring MJ
    Biochemistry; 1990 Jul; 29(26):6145-53. PubMed ID: 2207063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An NMR study of the interaction of daunomycin with dinucleotides and dinucleoside phosphates.
    Nuss ME; James TL; Apple MA; Kollman PA
    Biochim Biophys Acta; 1980 Aug; 609(1):136-47. PubMed ID: 7407180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of the daunomycin-DNA complex].
    Deprez-De Campeneere D
    Mem Acad R Med Belg; 1974; 47(4):215-57. PubMed ID: 4477631
    [No Abstract]   [Full Text] [Related]  

  • 32. Daunomycin unfolds compactly packed DNA.
    Yoshikawa Y; Yoshikawa K; Kanbe T
    Biophys Chem; 1996 Oct; 61(2-3):93-100. PubMed ID: 8956483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods.
    Bachur NR; Moore AL; Bernstein JG; Liu A
    Cancer Chemother Rep; 1970 Apr; 54(2):89-94. PubMed ID: 5527015
    [No Abstract]   [Full Text] [Related]  

  • 34. Site and sequence specificity of the daunomycin-DNA interaction.
    Chaires JB; Fox KR; Herrera JE; Britt M; Waring MJ
    Biochemistry; 1987 Dec; 26(25):8227-36. PubMed ID: 2831939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Recognition of Parallel G-quadruplex [d-(TTGGGGT)]₄ Containing
    Barthwal R; Tariq Z
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30189644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo studies on the distribution of 3H-daunomycin in tumours and in different tissues of the mouse.
    Di Fronzo G; Gambetta R
    Rev Eur Etud Clin Biol; 1971; 16(1):50-5. PubMed ID: 5108176
    [No Abstract]   [Full Text] [Related]  

  • 37. Microbial conversion of daunorubicin into N-acetyl-13(S)-dihydrodaunomycin and bisanhydro-13-dihydrodaunomycinone.
    Dornberger K; Hübener R; Ihn W; Thrum H; Radics L
    J Antibiot (Tokyo); 1985 Sep; 38(9):1219-25. PubMed ID: 4066504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study of daunomycin rats--is it possible to use daunomycin rats as an experimental model of chronic renal failure?].
    Shimizu K; Shibata M
    Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):345-51. PubMed ID: 2747007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperative multiple binding of bisANS and daunomycin to tubulin.
    Ward LD; Timasheff SN
    Biochemistry; 1994 Oct; 33(39):11891-9. PubMed ID: 7918408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of verapamil on the pharmacokinetics of daunomycin in the rat.
    Nooter K; Oostrum R; Deurloo J
    Cancer Chemother Pharmacol; 1987; 20(2):176-8. PubMed ID: 3664935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.